{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:00:32Z","timestamp":1793289632994,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","award":["RBSI14LOVD"],"award-info":[{"award-number":["RBSI14LOVD"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jhep.2017.10.020","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T19:18:43Z","timestamp":1509131923000},"page":"563-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":501,"title":["Clinical states of cirrhosis and competing risks"],"prefix":"10.1016","volume":"68","author":[{"given":"Gennaro","family":"D'Amico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Malizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rebora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.10.020_b0005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2017.10.020_b0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bmj.282.6260.263","article-title":"A 20-year prospective study of cirrhosis","volume":"282","author":"Saunders","year":"1981","journal-title":"Brit Med J"},{"key":"10.1016\/j.jhep.2017.10.020_b0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis. Natural history and prognostic factors","volume":"7","author":"Gin\u00e9s","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0025","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many stages where before there was one: in search of pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2009.31","article-title":"Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long term prospective study","volume":"104","author":"Bruno","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2012.10.023","article-title":"The matural history of compensated HCV-related cirrhosis: a prospective long-term study","volume":"58","author":"Vilar Gomez","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0040","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"The clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","author":"Zipprich","year":"2012","journal-title":"Liv Int"},{"key":"10.1016\/j.jhep.2017.10.020_b0050","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages in cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D\u2019Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2017.10.020_b0055","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.10.020_b0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdinamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0070","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilatation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0075","first-page":"407A","article-title":"The Laennec grading system for assessment of hepatic fibrosis: validation by correlation with wedged hepatic vein pressure and clinical features","volume":"32","author":"Kutami","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2005.07.036","article-title":"Histological\u2013hemodynamic correlation in cirrhosis\u2014a histological classification of the severity of cirrhosis","volume":"44","author":"Nagula","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0085","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/hep.24805","article-title":"Quantitative histological-hemodynamic correlations in cirrhosis","volume":"55","author":"Sethasine","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0090","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jhep.2011.02.012","article-title":"Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension","volume":"55","author":"Kim","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0095","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/his.12070","article-title":"Cirrhosis histology and Laennec staging system correlate with high portal pressure","volume":"62","author":"Rastogi","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.jhep.2017.10.020_b0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jhep.2017.10.020_b0105","series-title":"The statistical analysis of failure time data","author":"Kalbfleisch","year":"2002"},{"key":"10.1016\/j.jhep.2017.10.020_b0110","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: Possibilities and pitfalls","volume":"41","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhep.2017.10.020_b0115","series-title":"Competing risks. A practical perspective","author":"Pintile","year":"2006"},{"key":"10.1016\/j.jhep.2017.10.020_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1191\/0962280202SM276ra","article-title":"Multistate models for event history analysis","volume":"11","author":"Andersen","year":"2002","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jhep.2017.10.020_b0125","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0130","doi-asserted-by":"crossref","first-page":"G980","DOI":"10.1152\/ajpgi.00336.2005","article-title":"Mild increases in portal pressure up-regulate VEGF and eNOS in the intestinal microcirculation leading to hyperdynamic state","volume":"290","author":"Abraldes","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2017.10.020_b0135","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/gut.2010.235473","article-title":"Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis","volume":"60","author":"M\u00f8ller","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0140","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/hep.22745","article-title":"Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient","volume":"49","author":"Calvaruso","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0168-8278(00)80320-7","article-title":"Updating consensus in portal hypertension. Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension","volume":"33","author":"De Franchis","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0155","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/S0016-5085(01)80011-1","article-title":"The incidence of esophageal varices in cirrhosis","volume":"120","author":"D\u2019Amico","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1572-0241.2000.01775.x","article-title":"Natural history of cirrhotic patients with small esophageal varices: a prospective study","volume":"95","author":"Zoli","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0165","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"The North Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective study","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.10.020_b0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","article-title":"A MELD-Based model to determine risk of mortality among patients with acute variceal bleeding","volume":"146","author":"Reverter","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D'Amico","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0180","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0016-5085(81)90144-X","article-title":"The course of patients after variceal hemorrhage","volume":"80","author":"Graham","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.510250112","article-title":"Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis","volume":"25","author":"Bernard","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertrnsion. An evidence based Approach","volume":"19","author":"D\u2019Amico","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.10.020_b0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-149-2-200807150-00007","article-title":"Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis","volume":"149","author":"Gonzalez","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2017.10.020_b0200","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.29267","article-title":"Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis","volume":"66","author":"Albillos","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0205","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.10.020_b0210","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural History of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastro Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0215","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0225","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0230","doi-asserted-by":"crossref","first-page":"e0146076","DOI":"10.1371\/journal.pone.0146076","article-title":"Clinical and pathophysiological characteristics of cirrhotic patients with grade 1 and minimal hepatic encephalopathy","volume":"11","author":"Thomsen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.10.020_b0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy\u2013-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2017.10.020_b0240","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/ajg.2014.264","article-title":"Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization","volume":"109","author":"Patidar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0245","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0250","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0255","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0260","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0265","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal Failure and cirrhosis: a Systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0270","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice","volume":"55","author":"Salerno","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0280","doi-asserted-by":"crossref","unstructured":"Dionigi E, Garcovich M, Borzio M, Leandro G, Majumdar A, Tsami A et al. Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity. AJG 2017 e-published ahed of print. doi: 10.1038\/ajg.2017.19.","DOI":"10.1038\/ajg.2017.19"},{"key":"10.1016\/j.jhep.2017.10.020_b0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1590-8658(01)80134-1","article-title":"Bacterialinfectionin patients with advanced cirrhosis: a multicentre prospective study","volume":"33","author":"Borzio","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2017.10.020_b0290","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis","volume":"35","author":"Fernandez","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0295","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fernandez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0300","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/gutjnl-2012-302339","article-title":"Bacterial infections in end-stage liver disease: current challenges and future directions","volume":"61","author":"Bajaj","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0305","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2017.253","article-title":"Predictors of early readmission in patients with cirrhosis after the resolution of bacterial infections","author":"Piano","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0310","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0315","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increases mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0320","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2015-310275","article-title":"Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)","volume":"66","author":"Nahon","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0325","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MCG.0000000000000446","article-title":"Hepatocellular carcinoma screening and surveillance. practice guidelines and real-life practice","volume":"50","author":"Zhao","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0330","doi-asserted-by":"crossref","first-page":"s35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0335","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cgh.2007.02.039","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis","volume":"5","author":"Ioannou","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0340","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0345","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2006.08.011","article-title":"Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma","volume":"4","author":"Giannini","year":"2006","journal-title":"Clin Gastro Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0350","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0355","doi-asserted-by":"crossref","DOI":"10.1080\/00365521.2017.1335773","article-title":"Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy","author":"Shim","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0360","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.27443","article-title":"Prognosis of untreated hepatocellular carcinoma","volume":"61","author":"Giannini","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0365","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.10.020_b0370","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jhep.2015.10.029","article-title":"Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems","volume":"64","author":"Liu","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0375","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0380","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0036-1583202","article-title":"Acute-on-chronic liver failure: definition, diagnosis and clinical characteristics","volume":"36","author":"Arroyo","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.10.020_b0385","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0390","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0395","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0400","doi-asserted-by":"crossref","first-page":"32341","DOI":"10.1038\/srep32341","article-title":"Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis","volume":"6","author":"Sol\u00e9","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2017.10.020_b0405","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0036-1583199","article-title":"The pathogenesis of ACLF. The inflammatory response and immune function","volume":"36","author":"Moreau","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.10.020_b0410","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.1600818","article-title":"The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray","volume":"197","author":"Claria","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2017.10.020_b0415","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.27795","article-title":"Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults","volume":"62","author":"Shi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0036-1583204","article-title":"Acute-on chronic liver failure: the role of precipitating illness","volume":"36","author":"Sol\u00e0","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.10.020_b0425","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","author":"Fernandez","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0430","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis associated imuune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0435","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0440","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0445","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0450","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF consortium acute decompensation score (CLIF-C Ads) for prognosis of hospitalized cirrhotic patients without acute-on-cronich liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0455","doi-asserted-by":"crossref","first-page":"25487","DOI":"10.1038\/srep25487","article-title":"Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2017.10.020_b0460","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2017.07.008","article-title":"Incidence, predictors and outcome of acute-on-chronic liver failure in outpatients with cirrhosis","volume":"67","author":"Piano","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0465","first-page":"295","article-title":"Cirrhosis regression and subclassification","volume":"6","author":"Bedossa","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.jhep.2017.10.020_b0470","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A morphometric and immunoistochemical study to assess the benefit of sustained virological response in hepatitis c virus patients with cirrhosis","volume":"56","author":"D\u2019Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0475","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study","volume":"111","author":"Vorobioff","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0480","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.28992","article-title":"Effects of an intensive lifestyle intervention program on portal hypertension patients with cirrhosis and obesity: the sportdiet study","volume":"65","author":"Berzigotti","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0485","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0490","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jhep.2016.10.017","article-title":"Risk of cirrhosis related complications in patients with advanced fibrosis following hepatitis c virus eradication","volume":"66","author":"Van der Meer","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0495","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jhep.2016.01.034","article-title":"Survival of patients with HCV cirrhosis and sustained virological response is similar to the general population","volume":"64","author":"Bruno","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0500","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV related HCC undergoing interferon free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0505","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.gastro.2016.03.036","article-title":"Effects of eradicating hepatitis c virus infection in patients with cirrhosis differ with stage of portal hypertension","volume":"151","author":"Di Marco","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0510","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduce the risk of hepatocellular carcinoma","volume":"68","author":"Ioannau","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0515","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3350\/cmh.2016.0045","article-title":"The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy","volume":"22","author":"Varborbitis","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0520","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Baveno VI faculty. Expanding consensus in portal hypertension. Report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"De Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0525","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guideline on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"JHepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0530","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0168-8278(05)80315-0","article-title":"Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices. Copenhagen Esophageal Varices Sclerotherapy Project","volume":"21","author":"Thomsen","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0535","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management: 2016 practice guidance by the American Association for the Study of the Liver","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0540","doi-asserted-by":"crossref","unstructured":"Augustin S, Pons M, Santos B, Ventura M, Genesc\u00e0 J. Identifyinf chronic advanced liver disease: when not to start screening for varices and clinically significant portal hypertension. In de Franchis R ed: Portal hypertension VI. Proceeding of the sixth Baveno consensus workshop: stratifying risk and individualizing care. Springer international publishing Switzerland; 2016; 39\u201350.","DOI":"10.1007\/978-3-319-23018-4_5"},{"key":"10.1016\/j.jhep.2017.10.020_b0545","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0550","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the \u201canticipate\u201d study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0555","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2017.02.003","article-title":"Non-invasive evaluation of portal hypertension using ultrasound elastography","volume":"67","author":"Berzigotti","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0560","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01320309","article-title":"Survival and prognostic indicators in compensated and decompensated cirrhosis","volume":"31","author":"D'Amico","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2017.10.020_b0565","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensatedcirrhosis: natural history and prognostic factors","volume":"7","author":"Gin\u00e9s","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0570","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type c: A retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.020_b0575","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep.510290424","article-title":"The long-term outcomes of patients with compensated hepatitisC virus\u2013related cirrhosis and history of parenteral exposure in the united states","volume":"29","author":"Hu","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0580","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegn\u00f9","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0585","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus. A 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0590","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2010.04473.x","article-title":"The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study","volume":"32","author":"Fleming","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2017.10.020_b0595","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2007.10.008","article-title":"BoschJ. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy","volume":"48","author":"Abraldes","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0600","first-page":"329","article-title":"Natural history of compensated viral B and D cirrhosis","volume":"14","author":"Gheorghe","year":"2015","journal-title":"Rom J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0605","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","article-title":"Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C","volume":"43","author":"Sanyal","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0610","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0615","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2004.01.005","article-title":"Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients","volume":"40","author":"Planas","year":"2004","journal-title":"J Hepatoly"},{"key":"10.1016\/j.jhep.2017.10.020_b0620","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1478-3231.2005.01181.x","article-title":"Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients","volume":"26","author":"Sol\u00e0","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2017.10.020_b0625","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0168-8278(00)00011-8","article-title":"A prognostic model for predicting survival in cirrhosis with ascites","volume":"34","author":"Fern\u00e0ndez-Esparrach","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0630","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ajg.2013.110","article-title":"Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy","volume":"108","author":"Bruno","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0635","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/00365521.2015.1021709","article-title":"Complications of cirrhosis. A 50-yrs flashback","volume":"50","author":"Moller","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.020_b0640","doi-asserted-by":"crossref","first-page":"1254e1259","DOI":"10.1136\/gut.2010.235473","article-title":"Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis","volume":"60","author":"M\u00f8ller","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0645","doi-asserted-by":"crossref","first-page":"268e78","DOI":"10.1136\/gut.2006.112177","article-title":"Cardiovascular complications of cirrhosis","volume":"57","author":"M\u00f8ller","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0650","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.10.020_b0655","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal Failure in Cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.10.020_b0660","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis. A multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.020_b0665","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0036-1583198","article-title":"Management of acute-on-chronic liver failure","volume":"36","author":"Durand","year":"2016","journal-title":"Semin Liv Dis"},{"key":"10.1016\/j.jhep.2017.10.020_b0670","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/lt.24621","article-title":"Novel approach and therapeutics in acute on chronic liver failure","volume":"22","author":"Jalan","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2017.10.020_b0675","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis. The importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0680","series-title":"Epidemiology: An Introduction","author":"Rothman","year":"2002"},{"key":"10.1016\/j.jhep.2017.10.020_b0685","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Statist Med"},{"key":"10.1016\/j.jhep.2017.10.020_b0690","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Statist Soc B"},{"key":"10.1016\/j.jhep.2017.10.020_b0695","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Ass"},{"key":"10.1016\/j.jhep.2017.10.020_b0700","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/EDE.0b013e3181a39056","article-title":"Prognostic models with competing risks. Methods and application to coronary risk prediction","volume":"20","author":"Wolbers","year":"2009","journal-title":"Epidemiol"},{"key":"10.1016\/j.jhep.2017.10.020_b0705","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep.510280507","article-title":"Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, Randomized pragmatic trial","volume":"28","author":"D\u2019Amico","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.020_b0710","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2307\/2531021","article-title":"Sample-size formula for the proportional-hazards regression model","volume":"39","author":"Schoenfeld","year":"1983","journal-title":"Biometrics"},{"key":"10.1016\/j.jhep.2017.10.020_b0715","doi-asserted-by":"crossref","unstructured":"BC Tai, ZJ Chen, D Machin. Estimating sample size in the presence of competing risks \u2013 Cause-specific hazard or cumulative incidence approach? Stat Methods in Med Res First published date: December-27-2015 DOI 10.1177\/0962280215623107.","DOI":"10.1177\/0962280215623107"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817323991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817323991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T03:14:25Z","timestamp":1719544465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817323991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":143,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0168827817323991"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical states of cirrhosis and competing risks","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}